GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.
FDA Clears Elecsys pTau217 Blood Test: A Game-Changer for Alzheimer's Diagnosis
The FDA has cleared the Elecsys pTau217 blood test for Alzheimer's. Discover how this single-biomarker assay boosts primary care diagnostic accuracy from 65% to 93%.